November 30, 2023

Healthcare Global

Splash Healthcare Global All Over

Evolving Animal Healthcare: Global Antimicrobials and

NEWARK, Del, Aug. 29, 2023 (GLOBE NEWSWIRE) — In 2023, the Animal Antimicrobials and Antibiotics Market is to accumulate a market value of US$ 4,911.9 million. By 2033, this number is expected to expand to US$ 7,878.2 million, with a Compound Annual Growth Rate (CAGR) of 4.9%.

The demand for animal antimicrobials and antibiotics is on the rise during the forecast period due to the widespread use of several types of milk and meat products, especially in the Western diet.

Zoonotic illnesses and demand for animal-derived food products are also factors contributing to the rising demand for the products. Due to rising demand for pet insurance and rising expenditures for veterinary care, this market share for animal antimicrobials and antibiotics is expected to grow.

Animal antimicrobials and antibiotics market participants can expect tremendously rapid development thanks to the potential held by the untapped markets in China, India, and Brazil during the forecast period. The overall population of animals can also be seen to be on the rise, which is another great contributing factor.

Get the Sample PDF Report Now and Elevate Your Understanding @

Key Takeaways:

  • The United States holds a notable market share of 17.8% in the animal antimicrobials and antibiotics market in 2022, showcasing its significant role in the industry as a major consumer and contributor to the veterinary pharmaceutical sector.
  • Germany, with a market share of 6.6%, demonstrates its participation in the animal antimicrobials and antibiotics market, emphasizing the country’s commitment to animal health and welfare through the use of appropriate pharmaceutical interventions.
  • Japan’s market share in the animal antimicrobials and antibiotics market stands at 5.4% in 2022, reflecting the country’s focus on ensuring its livestock population’s well-being and disease management through the responsible use of antimicrobial products.
  • Australia contributes to the animal antimicrobials and antibiotics market with a market share of 1.0% in 2022, emphasizing the country’s attention to animal health and its efforts to mitigate the impact of infectious diseases through the judicious use of antimicrobials.
  • China exhibits a compound annual growth rate (CAGR) of 5.2% in the animal antimicrobials and antibiotics market, reflecting the country’s evolving livestock industry and the increasing demand for antimicrobial products to address animal health challenges and ensure food safety.
  • India experiences a robust CAGR of 9.6% in the animal antimicrobials and antibiotics market, highlighting the country’s expanding livestock sector and the growing need for effective disease management and growth promotion in the animal farming industry.
  • The United Kingdom showcases a CAGR of 5.9% in the animal antimicrobials and antibiotics market, indicating the country’s continuous efforts to promote responsible antimicrobial use, reduce the risk of antimicrobial resistance, and safeguard animal health and welfare in its agricultural practices.

Act Fast! Buy Now to Access Exclusive Market Segment Insights and Understand Your Industry Like Never Before:

Competitive Landscape

  • Trianni Inc. (US) and Zoetis (US) have decided to work together on developing transgenic monoclonal antibody platforms to discover innovative veterinary medications. This collaboration began in July 2020. The FDA approved Zoetis’ purchase of Marboquin (US).
  • Elanco (US) and AgBiome worked together to provide nutritional health solutions for pigs in 2019.
  • By balancing its food animal and companion animal divisions, Elanco Animal Health (US) announced in 2019 that it purchases Bayer’s Animal Health Business, boosting its own companion animal business and portfolio mix.
  • In 2019, Sanofi (France) purchased the Animal Health division of Boehringer Ingelheim (Germany) (Merial), and Boehringer Ingelheim (Germany) (CHC) was bought by Sanofi. After acquiring Merial, BI became the second-largest animal health firm in the world.

Key Companies Profiled in the Animal Antimicrobials and Antibiotics Market

  1. Bayer AG
  2. BoehringerIngelheim GmbH
  3. CevaSanteAnimale
  4. Dechra Pharmaceuticals PLC
  5. Eli Lilly and Company
  6. Merck & Co., Inc.
  7. Sanofi
  8. Vetoquinol S.A.
  9. Virbac
  10. Zoetis, Inc.
  11. Elanco Animal Health
  12. Phibro Animal Health
  13. Virbac
  14. Kyoritsu Seiyaku (Japan)
  15. Tianjin Ringpu
  16. HIPRA
  17. Zydus Animal Health
  18. Inovet

Lift the Veil on Our Methodological Excellence@

Animal Antimicrobials and Antibiotics Market by Category:

By Product Type:

  • Tetracyclines
  • Penicillins
  • Sulfonamides
  • Macrolides
  • Aminoglycosides
  • Lincosamides
  • Fluoroquinolones
  • Cephalosporins
  • Other Antimicrobials and Antibiotics

By Animal Type:

  • Companion Animals
  • Food Producing Animals

By Mode of Delivery:

  • Premixes
  • Oral Powder
  • Oral Solution
  • Injection

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Have a Look at Trending Reports in the Food and Beverage Domain:

Fortified Foods Market Size: In 2023, it is anticipated that demand for fortified foods would be US$ 140,608 million. The market value is anticipated to increase at a CAGR of 6.2% from 2023 to 2033, reaching US$ 257,715 million.

Vanillic Acid Market Share: In 2022, the global vanillic acid market had a value of US$20.1 billion. In 2023, demand is anticipated to exceed US$20.7 billion USD.

United States Pet Food Market Demand: Future Market Insights (FMI) predicts that from 2023 to 2033, the market for pet food in the United States would grow at a lucrative CAGR of 4.0%. The market is projected to rise from US$ 40,860.8 million in 2023 to US$ 60,234.0 million in 2033.

Pea Protein Market Growth: From 2023 to 2033, the size of the worldwide pea protein market is anticipated to grow at a CAGR of 7.0%. By the end of 2033, the market share value is anticipated to have increased from US$ 3,959.2 million in the current year 2023 to US$ 7,810.4 million.

Zinc Methionine Chelates Market Sales: The zinc methionine chelates market is anticipated to reach a value of US$ 14.2 million in 2023 and is anticipated to increase at a CAGR of 6.7% over the course of the forecast period, reaching US$ 27.3 million by 2033.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:         

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: [email protected]
LinkedIn| Twitter| Blogs | YouTube